Literature DB >> 27900023

Synchronous papillary urothelial carcinoma of the bladder and squamous cell carcinoma with sarcomatoid differentiation: A case report.

Mahizer Yaldiz1, Nur Cihan Cosansu1, Berna Solak1, Zeynep Kahyaoglu2, Mustafa Teoman Erdem1.   

Abstract

The incidence rate of multiple primary tumors is 37% in all types of cancer. A patient diagnosed with primary cancer is 1.29 times more likely to develop an additional primary cancer when compared with the general population. Furthermore, in patients diagnosed with primary cancer, the possibility of a secondary malignancy in the same or different organ is increased. Following the identification of a secondary tumor, the risk of relapse or metastasis must be considered. The present study reports the case of a 76-year-old man who was admitted to Sakarya University Training and Research Hospital (Sakarya, Turkey) with swelling of the head, which had been apparent for 15 days. An excisional biopsy of the temporal region was performed and was used to diagnose the patient with synchronous squamous cell carcinoma with sarcomatoid differentiation of the scalp. The patient was referred to the Department of Plastic Surgery (Sakarya University Training and Research Hospital) for resection; however, he refused treatment and was subsequently discharged. To the best of our knowledge, this patient represents the first case of synchronous skin malignancy and urothelial carcinoma of the bladder to be reported in the literature.

Entities:  

Keywords:  papillary urothelial carcinoma; squamous cell carcinoma; synchronous tumors

Year:  2016        PMID: 27900023      PMCID: PMC5103970          DOI: 10.3892/ol.2016.5064

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

1.  [Cases of multiple tumors in our clinic].

Authors:  A Antal; K Vallent
Journal:  Orv Hetil       Date:  1997-06-08       Impact factor: 0.540

2.  Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.

Authors:  G An; A Y Ng; C S Meka; G Luo; S P Bright; L Cazares; G L Wright; R W Veltri
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 3.  Patients with urologic cancer and other nonurologic malignancies: analysis of a sample and review of the literature.

Authors:  J H Mydlo; M Gerstein
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

4.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

5.  Second primary lung cancer: importance of long term follow up.

Authors:  P C van Bodegom; S S Wagenaar; B Corrin; J P Baak; J Berkel; R G Vanderschueren
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

6.  [Bilateral kidney cancer in a patient with Von Hippel-Lindau disease].

Authors:  S Conquy; A Steg; M Ferry
Journal:  Ann Urol (Paris)       Date:  1987

7.  Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors.

Authors:  M L López; A Lana; S Díaz; M V Folgueras; L Sánchez; M A Comendador; E Belyakova; J M Rodríguez; A Cueto
Journal:  Eur J Cancer Care (Engl)       Date:  2009-05-28       Impact factor: 2.520

8.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.

Authors:  T A Stamey; F S Freiha; J E McNeal; E A Redwine; A S Whittemore; H P Schmid
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

9.  Synchronous tumours of the breast and bladder.

Authors:  David Wallace; Dhilanthy Arul; Sudhanshu Chitale
Journal:  J Surg Case Rep       Date:  2014-07-01

10.  Synchronous primary neoplasms of the bladder, skin and breast in a male patient: a case report.

Authors:  Antonio Luigi Pastore; Giovanni Palleschi; Domenico Autieri; Antonino Leto; Andrea Ripoli; Cristina Maggioni; Davide Moschese; Yazan Al Salhi; Natale Porta; Claudio Di Cristofano; Andrea Fuschi; Luigi Silvestri; Carlo Della Rocca; Silverio Tomao; Vincenzo Petrozza; Antonio Carbone
Journal:  World J Surg Oncol       Date:  2013-10-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.